期刊文献+

贵阳市新生儿筛查中心新生儿先天性肾上腺皮质增生症筛查分析

Analysis of the screening results of neonatal congenital adrenal hyperplasia in Guiyang neonatal disease screening
下载PDF
导出
摘要 目的探讨贵阳市新生儿遗传代谢病筛查中心新生儿先天性肾上腺皮质增生症(CAH)的筛查数据,了解本地新生儿CAH的发病情况,总结筛查经验,讨论整改措施。方法对来自贵阳市65家助产机构出生于2019—2020年的118670例新生儿干血斑标本,应用时间分辨免疫荧光法分析干血滤纸片上的17-羟孕酮(17-hydroxyprogesterone,17-OHP)水平。结果在中心检测的118670名新生儿中,有6名被诊断患有CAH(男性3名,女性3名),CAH在本市的发生率为1∶19778。不同性别、出生体重、早产和足月儿组间17-OHP指标浓度值差异有统计学意义(P<0.05)。结论新生儿肾上腺皮质增生症筛查有利于对新生儿进行早期诊断及治疗。本病在贵阳地区的发病率为1∶19778。 Objective To analyze the screening data of neonatal congenital adrenal hyperplasia in Guiyang Neonatal Disease Screening Center and understand the incidence of CAH in local newborns,summarize the screening experience,and discuss corrective measures.Methods Use Time-resolved fluorescence to analyze the 17-hydroxyprogesterone(17-OHP)concentration of the neonatal dried blood spot on the filter paper were collected from 118670 newborns in 65 Maternal and Child Health Care Hospital.Results A total of 6 cases were diagnosed with congenital adrenal hyperplasia among the 118670 newborns.There were statistically significant differences in the concentration of 17-OHP between groups of different genders,birth weights,preterm and full-term infants(P<0.05).Conclusion CAH screening for newborns is conducive to early diagnosis and early treatment.The incidence of this disease in Guiyang is 1:19778.
作者 李林洁 杨雪 刘兴宇 张晓怡 Li Linjie;Yang Xue;Liu Xingyu;Zhang Xiaoyi(Department of Eugenics Genetics,Guiyang City Maternal and Child Health Care Hospital,Guiyang 550002,Guizhou,China)
出处 《贵州医药》 2024年第1期30-32,共3页 Guizhou Medical Journal
关键词 新生儿筛查 先天性肾上腺皮质增生症 17羟孕酮 Neonatal screening Congenital adrenocortical hyperplasia 17-Hydroxyprogesterone
  • 相关文献

参考文献5

二级参考文献36

  • 1顾学范,叶军.新生儿筛查[M].上海:上海科技文献出版社,2003.185-197.
  • 2吴圣嵋,陈惠金,朱建幸,等.新生儿医学[M].上海:上海科学技术出版社,2006:1001-1002.
  • 3Kamisawa T,Ryu JK,Kim MH,et al.Recent advances in the diagnosis and management of autoimmune pancreatitis:similarities and differences in Japan and Korea[J].Gut Liver,2013,7:394-400.
  • 4Gleeson HK,Wiley V,Wilcken B,et al.Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia[J].J Paediatr Child Health,2008,44:554-559.
  • 5Gru(n)ieiro-Papendieck L,Chiesa A,Mendez V,et al.Neonatal screening for congenital adrenal hyperplasia:experience and results in Argentina[J].J Pediatr Endocrinol Metab,2008,21:73-78.
  • 6Morikawa S,Nakamura A,Fujikura K,et al.Results from 28 years of newborn screening for congenital adrenal hyperplasia in sapporo[J].Clin Pediatr Endocrinol,2014,23:35-43.
  • 7Huet F,Godefroy A,Cheillan D,et al.Do we need congenital adrenal hyperplasia screening for premature infants?[J].Arch Pediatr,2014,21:233-236.
  • 8Gidl(o)f S,Wedell A,Guthenberg C,et al.Nationwide neonatal screening for congenital adrenal hyperplasia in sweden:a 26-year longitudinal prospective population-based study[J].JAMA Pediatr,2014,168:567-574.
  • 9Hayashi G, Faure C, Brondi MF, et al. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia. Arq Bras Endocrinol Metat:l, 2011, 55(8):632-637.
  • 10Vander Kamp HJ, Oudshoorn CG, Elvers BH, et al. Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should he based on gestational age rather than on birth weight. J Clin Endocrinol Metab, 2005, 90(7):3904-3907.

共引文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部